Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Ultrahigh field MRI in context of neurological diseases.]
Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.
Audiological evidence of therapeutic effect of steroid treatment in neuromyelitis optica with hearing loss.
Current standards of treatment in ms and the role of oral agents.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Botulinum Toxin-What Urologic Uses Does the Data Support?
TRO19622 Promotes Myelin Repair in a rat Model of Demyelination.
Potential Beneficial Effects of Marine Peptide on Human Neuron Health.
Novartis MS pill heads stream of SMC approvals
Transglutaminase 2 and neuroinflammation.
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis.
Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
Evidence for a multiple sclerosis epidemic?
Antibody index test may aid PML diagnosis on natalizumab
Vitamin D immunomodulatory potential in multiple sclerosis.
Neuroimaging biomarkers of neurodegenerative diseases and dementia.
Self-Efficacy as a Predictor of Self-Reported Physical, Cognitive, and Social Functioning in Multiple Sclerosis.
Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Voice-related quality of life in patients with multiple sclerosis.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Pages
« first
‹ previous
…
346
347
348
349
350
351
352
353
354
…
next ›
last »